rs147189192
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000620761.6(ACD):c.923G>A(p.Gly308Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00122 in 1,613,710 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G308G) has been classified as Likely benign.
Frequency
Consequence
ENST00000620761.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACD | NM_001082486.2 | c.923G>A | p.Gly308Glu | missense_variant | 10/12 | ENST00000620761.6 | NP_001075955.2 | |
ACD | NM_022914.3 | c.914G>A | p.Gly305Glu | missense_variant | 10/12 | NP_075065.3 | ||
ACD | NM_001410884.1 | c.836G>A | p.Gly279Glu | missense_variant | 9/11 | NP_001397813.1 | ||
ACD | XR_429728.4 | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACD | ENST00000620761.6 | c.923G>A | p.Gly308Glu | missense_variant | 10/12 | 1 | NM_001082486.2 | ENSP00000478084 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00626 AC: 953AN: 152128Hom.: 5 Cov.: 33
GnomAD3 exomes AF: 0.00147 AC: 367AN: 250392Hom.: 1 AF XY: 0.00104 AC XY: 141AN XY: 135508
GnomAD4 exome AF: 0.000690 AC: 1008AN: 1461464Hom.: 14 Cov.: 34 AF XY: 0.000615 AC XY: 447AN XY: 727026
GnomAD4 genome AF: 0.00626 AC: 953AN: 152246Hom.: 5 Cov.: 33 AF XY: 0.00595 AC XY: 443AN XY: 74438
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 31, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Aug 15, 2023 | - - |
Dyskeratosis congenita, autosomal dominant 6 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at